Pharmaceutical
| Wed 27 May 2026
Taipei, May 28 -- Morphic Therapeutic has filed a patent application for Inhibiting Human Integrin [alpha]5[beta]1. This invention was developed by Dowling James E, Babaoglu Kerim, Buckmelter Alex, Bursavich Matthew, Harrison Bryce, Lin Fu-yang, Lippa Blaise, Mcteague Thomas Andrew, Mondal Prolay, Monroy Meghan, Qiao Qi, Troast ..